Viewing Study NCT04404569


Ignite Creation Date: 2025-12-24 @ 11:02 PM
Ignite Modification Date: 2026-02-25 @ 9:39 PM
Study NCT ID: NCT04404569
Status: TERMINATED
Last Update Posted: 2024-12-20
First Post: 2020-05-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Continued Treatment for Participants Enrolled in Studies of BXQ-350
Sponsor: Bexion Pharmaceuticals, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None High-grade Glioma View
None Glioblastoma View
None Solid Tumor View